PulseAugur
中
实时 23:08:26

Study finds smaller AI models outperform large ones in drug discovery predictions

作者 PulseAugur 编辑部 · [2 个来源] ·

A new paper challenges the assumption that larger AI models are always superior in drug discovery. Researchers found that classical machine learning models and graph neural networks often outperform larger, general-purpose models on molecular property and activity prediction tasks. While large models may offer benefits in areas like zero-shot reasoning, their predictive advantage is not universal and depends heavily on specific task alignments. AI

影响 Suggests specialized, smaller models may be more effective for certain drug discovery prediction tasks than large, general-purpose AI.

排序理由 Academic paper evaluating model scaling performance on specific benchmarks.

在 arXiv cs.LG 阅读 →

AI 生成摘要 · Google Gemini · 来自 2 个来源。 我们如何撰写摘要 →

Study finds smaller AI models outperform large ones in drug discovery predictions

报道来源 [2]

  1. arXiv cs.LG TIER_1 English(EN) · Jinjiang Guo ·

    Do Larger Models Really Win in Drug Discovery? A Benchmark Assessment of Model Scaling in AI-Driven Molecular Property and Activity Prediction

    arXiv:2604.26498v1 Announce Type: new Abstract: The rapid growth of molecular foundation models and general-purpose large language models has encouraged a scale-centric view of artificial intelligence in drug discovery, in which larger pretrained models are expected to supersede …

  2. arXiv cs.LG TIER_1 English(EN) · Jinjiang Guo ·

    Do Larger Models Really Win in Drug Discovery? A Benchmark Assessment of Model Scaling in AI-Driven Molecular Property and Activity Prediction

    The rapid growth of molecular foundation models and general-purpose large language models has encouraged a scale-centric view of artificial intelligence in drug discovery, in which larger pretrained models are expected to supersede compact cheminformatics models and task-specific…

相关实体

相关话题